Levi & Korsinsky is investigating the Board of Directors of Questcor
Pharmaceuticals Inc. (“Questcor” or “the Company”) (NasdaqGS: QCOR) for
possible breaches of fiduciary duty and other violations of state law in
connection with the sale of the Company to Mallinckrodt.
Click here to learn more about the action http://zlk.9nl.com/questcor,
or call: 877-363-5972. There is no cost or obligation to you.
Under the terms of the transaction, Questcor shareholders will receive
$30.00 per share in cash and 0.897 Mallinckrodt shares for each share of
Questcor stock they own, representing a total value of approximately
$86.10 per share. The investigation concerns whether the Questcor Board
of directors breached their fiduciary duties to stockholders by failing
to adequately shop the Company before agreeing to enter into this
transaction, and whether Mallinckrodt is underpaying for Questcor shares.
If you own Questcor common stock and wish to obtain additional
information, please contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com
or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/questcor.
Levi & Korsinsky is a national firm with offices in New York, New
Jersey, Connecticut and Washington D.C. The firm’s 26 attorneys have
extensive expertise in prosecuting securities litigation involving
financial fraud, representing investors throughout the nation in
securities and shareholder lawsuits. For more information, please feel
free to contact any of the attorneys listed below. Attorney advertising.
Prior results do not guarantee similar outcomes.
Copyright Business Wire 2014